Skip to content

Geron GERN Common Stock

Common Stock at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$292M0.0%
Incyte logo
IncyteINCY
400M0.0%
Immunome logo
ImmunomeIMNM
$11K+22.2%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$9K0.0%
Arcus Biosciences logo
Arcus BiosciencesRCUS
400M0.0%
Celcuity logo
CelcuityCELC
95M0.0%

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$888.51M-8.6%
Enterprise value$973.78M-6.2%
P/S4.7×-174×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's common stock?
Geron (GERN) reported common stock of $641K in Q1 2026.
How has Geron's common stock changed year-over-year?
Geron's common stock increased by 0.6% year-over-year, from $637K to $641K.
What is the long-term trend for Geron's common stock?
Over 5 years (2020 to 2025), Geron's common stock has grown at a 15.6% compound annual growth rate (CAGR), from $310K to $640K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).